Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like Racial disparities persist in survival rates for young athletes with cardiac arrest March 31, 2025 Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults September 27, 2023 Advances in neutropenia research could pave the way for better treatments November 5, 2024
Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults September 27, 2023